Leopiras, Kathleen .

HRN: 20-08-19  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2026
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
01/03/2026
01/09/2026
ORAL
3ml
Q12
UTI
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: